96.8%
Nexiguran ziclumerancardiac amyloidosishereditary ATTR polyneuropathyA Fo Ben
…Nexiguran ziclumeran is the first in-human CRISPR therapy designed to silence transt…
2articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Nexiguran ziclumeran ×
Nexiguran ziclumeran
This drug is selected. Its supporting articles are shown below.
Articles mentioning Nexiguran ziclumeran
2 articles · page 1 of 1tafamidispatisiranvutrisiraninotersenAT-02acoramidiscormitugALXN220nexiguran ziclumeranTransthyretin amyloidosis+3 more
…atments available in clinical practice include TTR stabilisers (tafamidis and acoramidis), which prevent the dissociation of TTR tetramer…